articleThe Lancet Infectious DiseasesMay 23, 2024Closed access

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Hôpital Tenon · Sorbonne Université · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

158
total citations
FWCI
48.09
Percentile
100%
References
23
Citations per year

Authors

54

Topics & keywords

Keywords
  • Medicine
  • Incidence (geometry)
  • Doxycycline
  • Syphilis
  • Chlamydia
  • Population
  • Group B
  • Meningococcal vaccine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding